Momentum: 12 Biobased ventures raise $435M in Q2 2013; 32 projects being built off the balance sheet

Strategic investing

While JDAs have been hot of late, strategic investing has continued apace. As we profiled last November:

Total and Genting Genomics led a $104 million Series E round in Elevance in July.
Monsanto invested in Sapphire Energy’s $144 million Series C in April.
LANXESS invested in a $30M Series C in BioAmber.
Petronas and Dialog invested in a $56M Series C in LanzaTech in January.
BASF invested $30M in a Series C by Renmatix, the renewable sugars pioneer.
BP Ventures and Unilever Technology Ventures invested in Chromatin’s Series D Round.
Flint Hills invested in EdeniQ in March.
Itochu invested in ZeaChem in March.
Bunge invested in Cobalt Technologies’ Series E financing.

In today’s Digest, we explore 32 projects that are being funded off the balance sheet. All by following the page links below.